Maintain BUY. Given the promising data of SKB264 in 1L NSCLC and in late- line TNBC, we are more confident about SKB264’s global development and the approval in China. We raise our DCF-based TP from HK$200.77 to HK$246.13 (WACC: 10.31%, terminal growth rate: 4.0%)....